How should I manage a female patient with hyponatremia (serum sodium 121 mEq/L) and hyperkalemia (serum potassium 5.5 mEq/L) who has a urinary tract infection and an obstructing ureteric calculus?

Management of Hyponatremia and Hyperkalemia in Obstructive Ureteric Calculus with UTI

This patient requires immediate urinary tract decompression (percutaneous nephrostomy or retrograde ureteral stent) combined with broad-spectrum intravenous antibiotics and cautious correction of electrolyte abnormalities, as the obstructive uropathy with UTI is likely causing secondary pseudohypoaldosteronism that will resolve with infection treatment and relief of obstruction. 1, 2

Immediate Priorities

1. Urgent Urological Intervention

• Perform immediate urinary tract decompression via either percutaneous nephrostomy or retrograde ureteral stent placement to prevent progression to urosepsis and preserve renal function. 1

• Both decompression methods are equally acceptable with no clear superiority regarding infection resolution or complication rates. 1

• Collect urine for culture and susceptibility testing both before and after decompression. 1

2. Antibiotic Therapy

• Start broad-spectrum intravenous antibiotics immediately, ideally before decompression, to cover common uropathogens in complicated UTI. 1

• Appropriate empirical regimens include: 1

  • Amoxicillin + aminoglycoside
  • Second-generation cephalosporin + aminoglycoside
  • Intravenous third-generation cephalosporin

• Avoid fluoroquinolones if local resistance exceeds 10% or if the patient received fluoroquinolones within the preceding six months. 1

• Adjust antimicrobial therapy according to culture results and continue for 7-14 days based on resolution of obstruction. 1

Understanding the Electrolyte Abnormalities

Secondary Pseudohypoaldosteronism

• The combination of hyponatremia (Na 121 mEq/L) and hyperkalemia (K 5.5 mEq/L) in the setting of obstructive uropathy with UTI represents secondary pseudohypoaldosteronism—a transient renal tubular resistance to aldosterone. 2, 3

• This condition occurs when urinary tract infection complicates congenital or acquired urinary tract obstruction, causing temporary aldosterone resistance at the renal tubular level. 2, 4

• The electrolyte abnormalities typically resolve within approximately 1 week after treating the infection and relieving the obstruction with antibiotics and parenteral fluids. 2, 3

Electrolyte Management Strategy

Hyponatremia Correction (Na 121 mEq/L)

• This represents moderate hyponatremia (125-129 mEq/L range is moderate; <125 is severe). 5

• If the patient has severe symptoms (delirium, confusion, seizures, altered consciousness): 5

  • Administer 3% hypertonic saline emergently
  • Use calculators to guide fluid replacement and avoid overly rapid correction
  • Risk of osmotic demyelination syndrome with overcorrection

• If the patient is asymptomatic or has mild symptoms (nausea, vomiting, weakness, headache): 5

  • Treat with normal saline infusions (assuming hypovolemia from UTI/obstruction)
  • Correct underlying cause (infection and obstruction)
  • Monitor sodium closely during correction

• The hyponatremia will likely improve spontaneously as the pseudohypoaldosteronism resolves with treatment of the UTI and relief of obstruction. 2, 3

Hyperkalemia Management (K 5.5 mEq/L)

• At K 5.5 mEq/L, obtain immediate electrocardiography to assess for cardiac conduction abnormalities. 6

• If ECG shows abnormalities or patient has neuromuscular symptoms (muscle weakness, paralysis): 6

  • Intravenous calcium for cardiac membrane stabilization
  • Insulin with dextrose for transcellular shift
  • Sodium bicarbonate if metabolic acidosis present
  • Beta-agonists (albuterol nebulizer)
  • Loop diuretics if renal function permits

• If ECG is normal and patient asymptomatic: 6

  • Monitor closely with serial potassium measurements
  • Consider sodium polystyrene sulfonate or newer potassium binders (patiromer, sodium zirconium cyclosilicate)
  • Avoid sodium polystyrene sulfonate if possible due to serious gastrointestinal adverse effects 6

• The hyperkalemia will likely resolve within 1 week as the aldosterone resistance improves with infection treatment. 2, 3

Monitoring and Follow-up

• Monitor for sepsis progression using qSOFA criteria (respiratory rate ≥22/min, altered mental status, systolic BP ≤100 mmHg); sepsis development warrants intensive care management. 1

• Check renal function, as impaired kidney function occurs in approximately one-third of cases with secondary pseudohypoaldosteronism. 2

• Serial electrolyte monitoring every 4-6 hours initially until stabilized, then daily. 5, 6

• Expect normalization of sodium, potassium, and renal function within approximately 1 week with appropriate treatment. 2, 3

Definitive Stone Management

• Delay definitive stone removal (ureteroscopic lithotripsy, percutaneous nephrolithotomy, or ESWL) until the infection has completely resolved. 1

• Provide perioperative antibiotic prophylaxis for all endourological procedures performed after infection control. 1

Critical Pitfall to Avoid

• Do not attribute the electrolyte abnormalities solely to SIADH, adrenal insufficiency, or other causes without recognizing that obstructive uropathy with UTI itself causes transient pseudohypoaldosteronism. 2, 3, 4 The key is that treating the infection and relieving the obstruction will resolve the electrolyte disturbances without requiring long-term mineralocorticoid replacement.